vs

Side-by-side financial comparison of Option Care Health, Inc. (OPCH) and Rollins, Inc. (ROL). Click either name above to swap in a different company.

Option Care Health, Inc. is the larger business by last-quarter revenue ($1.5B vs $906.4M, roughly 1.6× Rollins, Inc.). Rollins, Inc. runs the higher net margin — 11.9% vs 4.0%, a 7.9% gap on every dollar of revenue. On growth, Rollins, Inc. posted the faster year-over-year revenue change (10.2% vs 8.8%). Over the past eight quarters, Option Care Health, Inc.'s revenue compounded faster (13.1% CAGR vs 0.8%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Rollins, Inc. is a North American pest control company serving residential and commercial clients. Operating globally through its wholly owned subsidiaries, Orkin, Inc., PCO Services, HomeTeam Pest Defense, Western Pest Services, Industrial Fumigant Company, TruTech, Critter Control, Crane, Waltham, OPC Services, PermaTreat, Northwest Exterminating, McCall Service and Clark Pest Control, as well UK subsidiaries Integrated Pest Management Limited, Safeguard Pest Control, NBC Environment, Europ...

OPCH vs ROL — Head-to-Head

Bigger by revenue
OPCH
OPCH
1.6× larger
OPCH
$1.5B
$906.4M
ROL
Growing faster (revenue YoY)
ROL
ROL
+1.4% gap
ROL
10.2%
8.8%
OPCH
Higher net margin
ROL
ROL
7.9% more per $
ROL
11.9%
4.0%
OPCH
Faster 2-yr revenue CAGR
OPCH
OPCH
Annualised
OPCH
13.1%
0.8%
ROL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OPCH
OPCH
ROL
ROL
Revenue
$1.5B
$906.4M
Net Profit
$58.5M
$107.8M
Gross Margin
19.3%
Operating Margin
6.2%
16.1%
Net Margin
4.0%
11.9%
Revenue YoY
8.8%
10.2%
Net Profit YoY
-2.7%
2.5%
EPS (diluted)
$0.37
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPCH
OPCH
ROL
ROL
Q1 26
$906.4M
Q4 25
$1.5B
$912.9M
Q3 25
$1.4B
$1.0B
Q2 25
$1.4B
$999.5M
Q1 25
$1.3B
$822.5M
Q4 24
$1.3B
$832.2M
Q3 24
$1.3B
$916.3M
Q2 24
$1.2B
$891.9M
Net Profit
OPCH
OPCH
ROL
ROL
Q1 26
$107.8M
Q4 25
$58.5M
$116.4M
Q3 25
$51.8M
$163.5M
Q2 25
$50.5M
$141.5M
Q1 25
$46.7M
$105.2M
Q4 24
$60.1M
$105.7M
Q3 24
$53.9M
$136.9M
Q2 24
$53.0M
$129.4M
Gross Margin
OPCH
OPCH
ROL
ROL
Q1 26
Q4 25
19.3%
Q3 25
19.0%
Q2 25
19.0%
Q1 25
19.7%
Q4 24
21.3%
Q3 24
20.1%
Q2 24
20.3%
Operating Margin
OPCH
OPCH
ROL
ROL
Q1 26
16.1%
Q4 25
6.2%
17.5%
Q3 25
5.9%
21.9%
Q2 25
5.8%
19.8%
Q1 25
5.9%
17.3%
Q4 24
6.9%
18.1%
Q3 24
6.7%
20.9%
Q2 24
6.6%
20.4%
Net Margin
OPCH
OPCH
ROL
ROL
Q1 26
11.9%
Q4 25
4.0%
12.8%
Q3 25
3.6%
15.9%
Q2 25
3.6%
14.2%
Q1 25
3.5%
12.8%
Q4 24
4.8%
12.7%
Q3 24
4.2%
14.9%
Q2 24
4.3%
14.5%
EPS (diluted)
OPCH
OPCH
ROL
ROL
Q1 26
$0.22
Q4 25
$0.37
$0.24
Q3 25
$0.32
$0.34
Q2 25
$0.31
$0.29
Q1 25
$0.28
$0.22
Q4 24
$0.36
$0.22
Q3 24
$0.31
$0.28
Q2 24
$0.30
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPCH
OPCH
ROL
ROL
Cash + ST InvestmentsLiquidity on hand
$232.6M
$116.5M
Total DebtLower is stronger
$650.6M
Stockholders' EquityBook value
$1.3B
$1.4B
Total Assets
$3.5B
$3.2B
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPCH
OPCH
ROL
ROL
Q1 26
$116.5M
Q4 25
$232.6M
$100.0M
Q3 25
$309.8M
$127.4M
Q2 25
$198.8M
$123.0M
Q1 25
$171.4M
$201.2M
Q4 24
$412.6M
$89.6M
Q3 24
$483.0M
$95.3M
Q2 24
$376.9M
$106.7M
Total Debt
OPCH
OPCH
ROL
ROL
Q1 26
$650.6M
Q4 25
$486.1M
Q3 25
$1.2B
$485.7M
Q2 25
$1.1B
$485.3M
Q1 25
$1.1B
$485.5M
Q4 24
$1.1B
$395.3M
Q3 24
$1.1B
Q2 24
$1.1B
Stockholders' Equity
OPCH
OPCH
ROL
ROL
Q1 26
$1.4B
Q4 25
$1.3B
$1.4B
Q3 25
$1.4B
$1.5B
Q2 25
$1.4B
$1.4B
Q1 25
$1.4B
$1.4B
Q4 24
$1.4B
$1.3B
Q3 24
$1.4B
$1.3B
Q2 24
$1.4B
$1.2B
Total Assets
OPCH
OPCH
ROL
ROL
Q1 26
$3.2B
Q4 25
$3.5B
$3.1B
Q3 25
$3.5B
$3.2B
Q2 25
$3.4B
$3.2B
Q1 25
$3.3B
$2.9B
Q4 24
$3.4B
$2.8B
Q3 24
$3.4B
$2.8B
Q2 24
$3.3B
$2.8B
Debt / Equity
OPCH
OPCH
ROL
ROL
Q1 26
0.47×
Q4 25
0.35×
Q3 25
0.86×
0.32×
Q2 25
0.82×
0.34×
Q1 25
0.82×
0.36×
Q4 24
0.79×
0.30×
Q3 24
0.78×
Q2 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPCH
OPCH
ROL
ROL
Operating Cash FlowLast quarter
$258.4M
$118.4M
Free Cash FlowOCF − Capex
$111.2M
FCF MarginFCF / Revenue
12.3%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
4.42×
1.10×
TTM Free Cash FlowTrailing 4 quarters
$621.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPCH
OPCH
ROL
ROL
Q1 26
$118.4M
Q4 25
$258.4M
$164.7M
Q3 25
$139.4M
$191.3M
Q2 25
$90.3M
$175.1M
Q1 25
$-7.2M
$146.9M
Q4 24
$36.1M
$188.2M
Q3 24
$160.4M
$146.9M
Q2 24
$195.7M
$145.1M
Free Cash Flow
OPCH
OPCH
ROL
ROL
Q1 26
$111.2M
Q4 25
$159.0M
Q3 25
$130.2M
$182.8M
Q2 25
$81.2M
$168.0M
Q1 25
$-16.6M
$140.1M
Q4 24
$25.8M
$184.0M
Q3 24
$150.7M
$139.4M
Q2 24
$185.9M
$136.4M
FCF Margin
OPCH
OPCH
ROL
ROL
Q1 26
12.3%
Q4 25
17.4%
Q3 25
9.1%
17.8%
Q2 25
5.7%
16.8%
Q1 25
-1.2%
17.0%
Q4 24
2.0%
22.1%
Q3 24
11.8%
15.2%
Q2 24
15.1%
15.3%
Capex Intensity
OPCH
OPCH
ROL
ROL
Q1 26
0.8%
Q4 25
0.6%
Q3 25
0.6%
0.8%
Q2 25
0.6%
0.7%
Q1 25
0.7%
0.8%
Q4 24
0.8%
0.5%
Q3 24
0.8%
0.8%
Q2 24
0.8%
1.0%
Cash Conversion
OPCH
OPCH
ROL
ROL
Q1 26
1.10×
Q4 25
4.42×
1.41×
Q3 25
2.69×
1.17×
Q2 25
1.79×
1.24×
Q1 25
-0.15×
1.40×
Q4 24
0.60×
1.78×
Q3 24
2.98×
1.07×
Q2 24
3.69×
1.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons